Bioorganic and Medicinal Chemistry Letters p. 6788 - 6792 (2009)
Update date:2022-08-04
Topics: Molecular docking Enzyme inhibition Inhibitor Derivative Selectivity Testing Structure-Activity Relationship (SAR) In vitro assay Kinase assay Benzimidazole IC50 (Half-Maximal Inhibitory Concentration) Pharmacophore Modeling
Cole, Andrew G.
Bohnstedt, Adolph C.
Paradkar, Vidyadhar
Kingsbury, Celia
Quintero, Jorge G.
Park, Haengsoon
Lu, Yingchun
You, Ming
Neagu, Irina
Diller, David J.
Letourneau, Jeffrey J.
Shao, Yuefei
James, Ray A.
Riviello, Christopher M.
Ho, Koc-Kan
Lin, Tsung H.
Wang, Bojing
Appell, Kenneth C.
Sills, Matthew
Quadros, Elizabeth
Kimble, Earl F.
Ohlmeyer, Michael H.J.
Webb, Maria L.
A novel class of Janus tyrosine kinase 3 (JAK3) inhibitors based on a 2-benzimidazoylpurinone core structure is described. Through substitution of the benzimidazoyl moiety and optimization of the N-9 substituent of the purinone, compound 24 was identified incorporating a chroman-based functional group. Compound 24 shows excellent kinase activity, good oral bioavailability and demonstrates efficacy in an acute mechanistic mouse model through inhibition of interleukin-2 (IL-2) induced interferon-γ (INF-γ) production.
View MoreChongqing Changfeng Chemical Co., Ltd.
website:http://www.changfengchem.com
Contact:+86-23-67896333
Address:30th Floor, Longhu Ziduxingzuo Building A, 1st Branch,YuSong Rd., Yubei District, Chongqing, China
Baoding City Light Industry And Textiles Imp.& Exp. Corp. Chemical Department.
Contact:86-312-3262436
Address:NO.658 CHAOYANG SOUTH STREET,BAODING CITY HEBEI CHINA
Contact:0086 533 2282832
Address:Zibo,Shandong
Cerametek Materials(ShenZhen)Co., Ltd.
Contact:+86-755-2324.2554
Address:A3-#9, YongChuan Street, Suite 501
SuZhou Bichal Biological Technology CO.,LTD
Contact:+86-512-68051130
Address:NO.32 huoju road HI-TECH Industrial development zone SuZhou China
Doi:10.1021/jm980170a
(1998)Doi:10.1055/s-1998-1738
(1998)Doi:10.1055/s-1998-1736
(1998)Doi:10.1039/a707386k
(1998)Doi:10.1016/S0040-4039(98)00793-X
(1998)Doi:10.1039/c6ra20676j
(2016)